ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,204 | -14.6% | 8,462 | -4.1% | 0.01% | -12.5% |
| Q2 2023 | $253,130 | -16.1% | 8,826 | -29.9% | 0.02% | -11.1% |
| Q1 2023 | $301,878 | +63.2% | 12,594 | +7.2% | 0.02% | +260.0% |
| Q2 2022 | $185,000 | -67.0% | 11,753 | -8.9% | 0.01% | -64.3% |
| Q4 2020 | $560,000 | -76.6% | 12,900 | -76.9% | 0.01% | -87.9% |
| Q3 2020 | $2,391,000 | +555.1% | 55,727 | +614.4% | 0.12% | +480.0% |
| Q2 2020 | $365,000 | -14.3% | 7,800 | -75.1% | 0.02% | -31.0% |
| Q1 2020 | $426,000 | +27.2% | 31,339 | +1.5% | 0.03% | +123.1% |
| Q4 2019 | $335,000 | +44.4% | 30,861 | +36.4% | 0.01% | +30.0% |
| Q3 2019 | $232,000 | +40.6% | 22,630 | +29.2% | 0.01% | +25.0% |
| Q2 2019 | $165,000 | – | 17,517 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |